Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 15266

Fort Lauderdale, FL 33308


Study Summary:

A randomized, double-blind, placebo-controled, phase 3 study to evaluate the efficacy, safety, and tolerablility of JNJ-27018966 in the treatment of patients with diarrhea-predominant Irritable Bowel Syndrome.


Qualified Participants Must:

• Be 18 to 80 years of age
• Have a diagnosis of IBS with a subtype of diarrhea
• Have had a colonoscopy in last 10 years, if 50 years old or greater
• Have pain of >3.0 on a scale of 1-10 in the last week
• Be able to complete electronic daily diaries
• Average daily stool consistency score (BSS) of > or equal to 5.5
• Meet other qualifying factors that will be discussed with study staff


Qualified Participants May Receive:

You will be paid $50.00 for study visits you complete.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.